-
Decontamination strategies and bloodstream infections with antibiotic-resistant microorganisms in ventilated patients [Elektronski vir] : a randomized clinical trialWittekamp, Bastiaan H. ...Importance: The effects of chlorhexidine (CHX) mouthwash, selective oropharyngeal decontamination (SOD), and selective digestive tract decontamination (SDD) on patient outcomes in ICUs with moderate ... to high levels of antibiotic resistance are unknown. Objective: To determine associations between CHX 2%, SOD, and SDD and the occurrence of ICU-acquired bloodstream infections with multidrug-resistant gram-negative bacteria (MDRGNB) and 28-day mortality in ICUs with moderate to high levels of antibiotic resistance. Design, setting, and participants: Randomized trial conducted from December 1, 2013, to May 31, 2017, in 13 European ICUs where at least 5% of bloodstream infections are caused by extended-spectrum [beta]-lactamase-producing Enterobacteriaceae. Patients with anticipated mechanical ventilation of more than 24 hours were eligible. The final date of follow-up was September 20, 2017. Interventions: Standard care was daily CHX 2% body washings and a hand hygiene improvement program. Following a baseline period from 6 to 14 months, each ICU was assigned in random order to 3 separate 6-month intervention periods with either CHX 2% mouthwash, SOD (mouthpaste with colistin, tobramycin, and nystatin), or SDD (the same mouthpaste and gastrointestinal suspension with the same antibiotics), all applied 4 times daily. Main outcomes and measures: The occurrence of ICU-acquired bloodstream infection with MDRGNB (primary outcome) and 28-day mortality (secondary outcome) during each intervention period compared with the baseline period. Results: A total of 8665 patients (median age, 64.1 years; 5561 men [64.2%]) were included in the study (2251, 2108, 2224, and 2082 in the baseline, CHX, SOD, and SDD periods, respectively). ICU-acquired bloodstream infection with MDRGNB occurred among 144 patients (154 episodes) in 2.1%, 1.8%, 1.5%, and 1.2% of included patients during the baseline, CHX, SOD, and SDD periods, respectively. Absolute risk reductions were 0.3% (95% CI, -0.6% to 1.1%), 0.6% (95% CI, -0.2% to 1.4%), and 0.8% (95% CI, 0.1% to 1.6%) for CHX, SOD, and SDD, respectively, compared with baseline. Adjusted hazard ratios were 1.13 (95% CI, 0.68-1.88), 0.89 (95% CI, 0.55-1.45), and 0.70 (95% CI, 0.43-1.14) during the CHX, SOD, and SDD periods, respectively, vs baseline. Crude mortality risks on day 28 were 31.9%, 32.9%, 32.4%, and 34.1% during the baseline, CHX, SOD, and SDD periods, respectively. Adjusted odds ratios for 28-day mortality were 1.07 (95% CI, 0.86-1.32), 1.05 (95% CI, 0.85-1.29), and 1.03 (95% CI, 0.80-1.32) for CHX, SOD, and SDD, respectively, vs baseline. Conclusions and relevance: Among patients receiving mechanical ventilation in ICUs with moderate to high antibiotic resistance prevalence, use of CHX mouthwash, SOD, or SDD was not associated with reductions in ICU-acquired bloodstream infections caused by MDRGNB compared with standard care.Vir: JAMA [Elektronski vir]. - ISSN 1538-3598 (Vol. 320, no. 20, Nov. 2018, str. 2087-2098)Vrsta gradiva - e-članek ; neleposlovje za odrasleLeto - 2018Jezik - angleškiCOBISS.SI-ID - 2048463473
Avtor
Wittekamp, Bastiaan H. |
Plantinga, Nienke L. |
Cooper, Ben S. |
Lopez-Contreras, Joaquin |
Coll, Pere |
Mancebo, Jordi, 1957- |
Wise, Matt P. |
Morgan, Matt P. G. |
Depuydt, Pieter |
Boelens, Jerina |
Tomič, Viktorija |
Šifrer, Franc, dr. med., spec., 1960-
Teme
Anti-infective agents |
Therapeutic use |
Bacteremia |
Prevention and control |
Chlorhexidine |
Therapeutic use |
Cross infection |
Prevention and control |
Disinfection |
Methods |
Drug resistance, bacterial |
Gastrointestinal tract |
Microbiology |
Gram-negative bacterial infections |
Prevention and control |
Hospital mortality |
Intensive care units |
Mouthwashes |
Therapeutic use |
Oropharynx |
Microbiology |
Respiration, artificial |
Sredstva proti okužbam |
Terapevtska raba |
Bakteriemija |
Preprečevanje in nadzor |
Klorheksidin |
Terapevtska raba |
Navzkrižne okužbe |
Preprečevanje in nadzor |
Razkuževanje |
Metode |
Bakterijska odpornost na zdravila |
Gastrointestinalni trakt |
Mikrobiologija |
Gramnegativne bakterijske okužbe |
Preprečevanje in nadzor |
Bolnišnična umrljivost |
Enote za intenzivno oskrbo |
Ustne vode |
Terapevtska raba |
Orofarinks |
Mikrobiologija |
Umetna respiracija |
Multicenter study |
Multicentrična študija |
Randomized controlled trial |
Naključni nadzorovani poskus
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Wittekamp, Bastiaan H. | ![]() |
Plantinga, Nienke L. | ![]() |
Cooper, Ben S. | ![]() |
Lopez-Contreras, Joaquin | ![]() |
Coll, Pere | ![]() |
Mancebo, Jordi, 1957- | ![]() |
Wise, Matt P. | ![]() |
Morgan, Matt P. G. | ![]() |
Depuydt, Pieter | ![]() |
Boelens, Jerina | ![]() |
Tomič, Viktorija | 22806 |
Šifrer, Franc, dr. med., spec., 1960- | ![]() |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.